Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses

Back

ESC Professional Premium Access

Remnant cholesterol lowering in cardiovascular disease risk reduction in statin trials: meta-regression analyses

Session: Lipids as risk factor for heart disease

Topic: Lipids

Speaker: Doctor A. Nordestgaard (Boston, US)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ask Tybjaerg Nordestgaard

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

0 follower

7 more presentations in this session

Participation rate and yield of indirect cascade genetic screening for familial hypercholesterolemia using a web-based communication platform (CATCH): a randomized multicenter implementation trial

Speaker: Assistant Professor D. Nanchen (Lausanne, CH)

Burden and sociodemographic disparities in cardiovascular mortality rates associated with hypercholesterolemia in united states: a nationwide county-level analysis from 2010 to 2019

Speaker: Doctor S. Abohashem (Boston, US)

Remnant cholesterol and cardiovascular and all-cause mortality in Korean adults

Speaker: Professor B. Kim (Seoul, KR)

Impact of measured or calculated small dense LDL cholesterol compared with apolipoprotein B or non-HDL cholesterol for long-term secondary prevention in patients with stable coronary artery disease

Speaker: Professor S. Koba (Tokyo, JP)

Prognostic role of remnant cholesterol and traditional cardiovascular risk factors in young adults: results of long-term follow-up of a cohort of 30-year-old norwegians.

Speaker: Doctor E. Aaseth (Oslo, NO)

Access the full session

Lipids as risk factor for heart disease

Speakers: Doctor A. Nordestgaard, Assistant Professor D. Nanchen, Doctor S. Abohashem, Professor B. Kim, Professor S. Koba...

Access

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources